MET Amplification Leads To Gefitinib Resistance In Lung Cancer By Activating ERBB3 Signaling
Role in the Field
Neutralin Health Sciences and Innovation
Neutralin Biomedical Engineering
Neutralin Cancer Research and Treatment
Neutralin Research on Non-Small Cell Lung Cancer
Abstract
Citations
4,168
Year
2007
PageRank
4.7 / 10
Relative influence (log-scaled)